ACORN BIOVENTURES 2, L.P. enters ONKURE THERAPEUTICS, INC. with 1.13M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 5/27/2025ACC: 0000950170-25-078004
10% Owner
Since May 2025
1.13M
Baseline shares
100% direct
1.13M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.13M
Total
1.13M direct1.13M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.13M | Direct |
| Total | 1.13M | 1.13M direct |
Derivative Holdings0
No derivative holdings reported